[Pick-A-Hill2019]

This Open Letter is bullshit (purely personal opinion obviously). I note they are transparent about the pricing in specific markets but that the CEO fails to be so transparent about the pricing for generics in other markets. I’m aware of the studies regarding its effectiveness but hate hand-wavy B.S. like this so here's some snippets taken from Gilead's own website.

"All descriptive printed matter, including advertising and promotional material, relating to the use of the remdesivir clearly and conspicuously shall state that: :the remdesivir have not been approved [sic] :the remdesivir have been authorized by FDA under an EUA [sic]" page 6 https://www.gilead.com/-/media/files/pdfs/remdesivir/eua-fda...

and "Remdesivir is an investigational drug that has not been approved by the FDA for any use." https://www.gilead.com/remdesivir

I was in two minds about correcting the grammar but since they are all snips from the links decided to leave as is.

[Edit to clarify] My main point was that if they were pricing generics at a reasonable price they would have been trumpeting in the same press release as this. eg. if one is so reasonable that they openly discuss it then why not the pricing of generics.